An analysis of the relative risk for hypothyroidism in patients with Type2 diabetes

Diabetic Medicine

Volumn 29, Issue 12, 2012, Pages 1510-1514

  Diez J J ^a   Iglesias, P ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; THYROID ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHYROIDISM; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK FACTOR; SCREENING; VASCULAR DISEASE;

AGED; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; HYPOTHYROIDISM; LOGISTIC MODELS; MALE; METFORMIN; ODDS RATIO; PREVALENCE; RISK; THYROTROPIN; THYROXINE;

EID: 84869121318     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03687.x     Document Type: Article

References (26)

1. Michalek AM, Mahoney MC, Calebaugh D. Hypothyroidism and diabetes mellitus in an American Indian population. J Fam Pract 2000; 49: 638-640.
2. Warren RE, Perros P, Nyirenda MJ, Frier BM. Serum thyrotropin is a better predictor of future thyroid dysfunction than thyroid autoantibody status in biochemically euthyroid patients with diabetes: implications for screening. Thyroid 2004; 14: 853-857.
3. Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 1995; 12: 622-627.
4. Smithson MJ. Screening for thyroid dysfunction in a community population of diabetic patients. Diabet Med 1998; 15: 148-150.
5. Matejkova-Behanova M, Zamrazil V, Vondra K, Vrbikova J, Kucera P, Hill M et al. Autoimmune thyroiditis in non-obese subjects with initial diagnosis of Type2 diabetes mellitus. J Endocrinol Invest 2002; 25: 779-784.
6. Radaideh ARM, Nusier MK, Amari FL, Bateiha AE, El-Khateeb MS, Naser AS et al. Thyroid dysfunction in patients with type2 diabetes mellitus in Jordan. Saudi Med J 2004; 25: 1046-1050.
7. Chubb SAP, Davis WA, Inman Z, Davis TME. Prevalence and progression of subclinical hypothyroidism in women with type2 diabetes: the Freemantle Diabetes Study. Clin Endocrinol (Oxf) 2005; 62: 480-486.
8. Ishay A, Chertok-Shaham I, Lavi I, Luboshitzky R. Prevalence of subclinical hypothyroidism in women with type2 diabetes. Med Sci Monit 2009; 15: CR151-CR155.
9. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANESIII). J Clin Endocrinol Metab 2002; 87: 489-499.
10. Díez JJ, Sánchez P, Iglesias P. Prevalence of thyroid dysfunction in patients with type2 diabetes. Exp Clin Endocrinol Diabetes 2011; 119: 201-207.
11. Akbar DH, Ahmed MM, Al-Mughales J. Thyroid dysfunction and thyroid autoimmunity in Saudi type2 diabetics. Acta Diabetol 2006; 43: 14-18.
12. Gopinath B, Wang JJ, Kifley A, Wall JR, Leeder SR, Mitchell P. Type2 diabetes does not predict incident thyroid dysfunction in the elderly. Diabetes Res Clin Pract 2008; 82: e11-e13.
13. Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F et al. Increased risk for endocrine autoimmunity in Italian type2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol (Oxf) 2000; 52: 565-573.
14. Chen HS, Wu TEJ, Jap TS, Lu RA, Wang ML, Chen RL et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type2 diabetic patients. Diabet Med 2007; 24: 1336-1344.
15. Razvi S, Weaver JU, Vanderpump MP, Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab 2010; 95: 1734-1740.
16. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. J Am Med Assoc 2010; 304: 1365-1374.
17. McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS Database Study. Thyroid 2011; 21: 837-843.
18. Isidro ML, Penín MA, Nemiña R, Cordido F. Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine 2007; 32: 79-82.
19. Cappelli C, Rotondi M, Pirola I, Agosti B, Gandossi E, Valentini U et al. TSH-lowering effect of metformin in type2 diabetic patients. Diabetes Care 2009; 32: 1589-1590.
20. Díez JJ, Iglesias P. Subclinical hypothyroidism in women with type2 diabetes. Clin Endocrinol (Oxf) 2005; 63: 479-480.
21. Maratou E, Hadjidakis DJ, Kollinas A, Tsegka K, Peppa M, Alevizaki M et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009; 160: 785-790.
22. Handisurya A, Pacini G, Tura A. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clin Endocrinol (Oxf) 2008; 69: 963-969.
23. American Association of Clinical Endocrinologists. The American Association of Clinical Endocrinologists medical guidelines for the management of diabetes mellitus: the ACCE system of intensive diabetes self-management, 2000 update. Endocr Pract 2000; 6: 43-84.
24. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002; 8: 457-469.
25. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care 2009; 32: S13-S61.
26. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG et al. American Thyroid Society guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160: 1573-1575.